SARS-CoV-2 papain-like protease plays multiple roles in regulating cellular proteins in the endoplasmic reticulum DOI Creative Commons
Mei Yang, Jennifer Mariano, R. Su

и другие.

Journal of Biological Chemistry, Год журнала: 2023, Номер 299(12), С. 105346 - 105346

Опубликована: Окт. 12, 2023

Nsp3s are the largest nonstructural proteins of coronaviruses. These transmembrane include papain-like proteases (PLpro) that play essential roles in cleaving viral polyproteins into their mature units. The PLpro SARS-CoV viruses also have deubiquitinating and deISGylating activities. As Nsp3 is an endoplasmic reticulum (ER)-localized protein, we asked if activity SARS-CoV-2 affects substrates for ER-associated degradation (ERAD). Using full-length as well a truncated form interrogated, by coexpression, three potential ERAD substrates, all which regulating lipid biosynthesis. Transmembrane increases level INSIG-1 decreases its ubiquitination. However, different effects were seen with SREBP-1 SREBP-2. cleaves at sites, including two noncanonical sites N-terminal half resulting decrease precursors active transcription factor. Conversely, cleavage SREBP-2 occurs single canonical site disrupts C-terminal degron, increased levels. When this mutated degron can no longer be interrupted, still stabilized PLpro, correlates All these observations dependent on catalytic activity. Our findings demonstrate that, when anchored to ER membrane, function enzyme stabilize substrates. Additionally, cleave ER-resident proteins, could escape analyses based established consensus sequence. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pathogen responsible COVID-19 pandemic. Nonstructural protein 3 (Nsp3), (CoV) synthesized polyprotein other Nsps. domains variety functions related pathogenesis localize them (ER) expressed alone or during initial phases infection. Topologically, but short region binds Nsp4 faces cytosol. Nsp4, together Nsp6, required double membrane ER-derived replication/transcription complex (1Lei J. Kusov Y. Hilgenfeld R. coronaviruses: structures large multi-domain protein.Antivir. Res. 2018; 149: 58-74Google Scholar, 2Kanjanahaluethai A. Chen Z. Jukneliene D. Baker S.C. Membrane topology murine replicase 3.Virology. 2007; 361: 391-401Google 3Santerre M. Arjona S.P. Allen C.N. Shcherbik N. Sawaya B.E. Why do NSPs rush ER.J. Neurol. 2021; 268: 2013-2022Google 4Hackstadt T. Chiramel A.I. Hoyt F.H. Williamson B.N. Dooley C.A. Beare P.A. et al.Disruption Golgi apparatus contribution replication complex.Viruses. 13: 1798Google Scholar). genus beta-CoV, comprises SARS-CoV-1 Middle East (MERS)-CoV, protease composed ubiquitin-like domain domain. situated N terminal domains, plays role CoV constituent releasing Nsp1, Nsp2, itself Other cleavages carried out Nsp5 3CLpro (5Moustaqil Ollivier E. Chiu H.P. Van Tol S. Rudolffi-Soto P. Stevens C. al.SARS-CoV-2 IRF3 critical modulators inflammatory pathways (NLRP12 TAB1): implications disease presentation across species.Emerg. Microbes Infect. 10: 178-195Google For MERS, SARS-CoV-1, SARS-CoV-2, L(P4)X(P3)G(P2)G(P1), using numbering system Schechter Berger (6Schechter I. On size proteases. Papain.Biochem. Biophys. Commun. 1967; 27: 157-162Google Scholar), where after P1 Gly. An exception Nsp3-Nsp4 MERS Ile found P4 (7Ullrich Nitsche protease: structure, inhibition.Chembiochem. 2022; 23e202200327Google In addition endoprotease polyproteins, some coronaviruses, those noted above, remove both polyubiquitin chains ISG15 from (8Barretto Ratia K. Mesecar A.D. severe has activity.J. Virol. 2005; 79: 15189-15198Google 9Mielech A.M. Kilianski Baez-Santos Y.M. MERS-CoV activities.Virology. 2014; 450-451: 64-70Google 10Lindner H.A. Fotouhi-Ardakani Lytvyn V. Lachance Sulea Ménard enzyme.J. 15199-15208Google modifiers linked through C termini, terminate LRGG. preference removing (11Shin Mukherjee Grewe Bojkova Baek Bhattacharya al.Papain-like regulates spread innate immunity.Nature. 2020; 587: 657-662Google 12Klemm Ebert G. Calleja D.J. Allison C.C. Richardson L.W. Bernardini J.P. al.Mechanism inhibition protease, SARS-CoV-2.EMBO 39e106275Google 13Rut W. Lv Zmudzinski Patchett Nayak Snipas S.J. al.Activity profiling crystal inhibitor-bound framework anti-COVID-19 drug design.Sci. Adv. 6: eabd4596Google 14Freitas B.T. Durie I.A. Murray Longo J.E. Miller H.C. Crich al.Characterization noncovalent deubiquitinase deISGylase protease.ACS Dis. 2099-2109Google while higher toward K48-linked diubiquitin (15Békés Rut Kasperkiewicz Mulder M.P. Ovaa H. Drag al.SARS hCoV unique Lys48 linkage-specific di-distributive enzyme.Biochem. 2015; 468: 215-226Google 16Békés van der Heden Noort G.J. Ekkebus Huang T.T. Lima C.D. Recognition Lys48-linked di-ubiquitin activities SARS protease.Mol. Cell. 2016; 62: 572-585Google 17Lindner Qi Ziomek Selectivity ubiquitin recognition protease.Arch. Biochem. 466: 8-14Google 18Ratia Structural Basis Ubiquitin-Linkage Specificity protease.PLoS Pathog. 10e1004113Google differences been ascribed diminished linkages due alterations S1 (19Patchett Békés Olsen S.K. al.A molecular sensor determines substrate specificity protease.Cell Rep. 36109754Google studies ubiquitination focused antagonistic might (DUB) activators immunity mediated type 1 interferon (IFN) response. Here, multiple activating signaling K63 linkages, rather than targeting degradation. several examining either soluble cytoplasmic attenuation IFN response was independent attributed disruption protein–protein interactions (20Devaraj S.G. Wang Tseng Barretto al.Regulation IRF-3-dependent coronavirus.J. Biol. Chem. 282: 32208-32221Google 21Chen X. Yang Zheng Xing inhibits I pathway interaction STING-TRAF3-TBK1 complex.Protein 5: 369-381Google 22Sun L. Nichols D.B. al.Coronavirus negatively regulate antiviral immune STING-mediated signaling.PLoS One. 2012; 7e30802Google 23Frieman Johnston R.E. Baric R.S. antagonism NF-kappaB signaling.J. 2009; 83: 6689-6705Google study assessing cytosolic activation, requirement DUB some, not other, mediators (24Ran X.H. Zhu J.W. Y.Y. Ni R.Z. Mu Papain-like RLR deubiquitination-dependent deubiquitination-independent manner.Front. Immunol. 13947272Google Another recent suppress induced stimulator genes (STING) overexpression (25Cao Duan B. Xiong Zhang suppresses responses STING.Sci. Signal. 2023; 16eadd0082Google undergoes ER. This contrasts previous work employing decreased STING activation (21Chen It remains unclear whether versus forms same would impact requirements what overall importance tethering suppression PLpro. Nevertheless, there substantial data suggest dispensable oppose molecules integral response, hub signaling, cellular stress leading cholesterol fatty acid Proteins others regulated part proteasome-dependent homeostatic process known (ERAD), central quality control (26Olzmann J.A. Kopito R.R. Christianson J.C. mammalian reticulum-associated system.Cold Spring Harb. Perspect. 2013; a013185Google 27Sun Brodsky J.L. Protein secretory pathway.J. Cell 2019; 218: 3171-3187Google 28Bhattacharya health - organism.J. Sci. 132: jcs232850Google 29Mehrtash A.B. Hochstrasser Ubiquitin-dependent nuclear envelope.Semin. Dev. 93: 111-124Google Activation biosynthesis trafficking sterol regulatory element–binding (SREBP) -1 -2 bound SREBP cleavage–activating (SCAP) Golgi. takes place upon release insulin–induced (INSIG) –1 stimuli depletion (30Brown M.S. Goldstein pathway: regulation metabolism proteolysis membrane-bound factor.Cell. 1997; 89: 331-340Google 31Shimano Sato SREBP-regulated metabolism: convergent physiology divergent pathophysiology.Nat. Rev. Endocrinol. 2017; 710-730Google INSIG-1, particular, extensively characterized short-lived (31Shimano 32Lee J.N. Song DeBose-Boyd R.A. Ye Sterol-regulated Insig-1 ligase gp78.J. 2006; 281: 39308-39315Google 33Tsai Y.C. Leichner G.S. Pearce M.M. Wilson G.L. Wojcikiewicz R.J. Roitelman al.Differential HMG-CoA reductase enzymes ubiquitin-proteasome system.Mol. 23: 4484-4494Google 34Faulkner Nguyen Jo Lipid-regulated distinct mechanisms insect cells.J. Lipid 54: 1011-1022Google 35Leto D.E. Morgens D.W. Walczak C.P. Elias Bassik M.C. al.Genome-wide CRISPR analysis identifies substrate-specific conjugation modules degradation.Mol. 73: 377-389.e11Google 36Smith C.E. Tsai Liang Y.H. Khago Mariano Li structurally conserved AUP1 E2 UBE2G2 degradation.PLoS 19e3001474Google Golgi, SREBPs undergo endoproteolytic S1P S2P, (NTDs), constitute factors 37Duncan E.A. Brown Sakai Cleavage sterol-regulated localized leu-Ser bond lumenal loop element-binding protein-2.J. 272: 12778-12785Google 38Duncan Davé U.P. Second-site junction determined cysteine panning.J. 1998; 273: 17801-17809Google reported targeted (39Hughes Nwosu Espenshade P.J. Degradation precursor requires components Ubc7 Hrd1 fission yeast.J. 284: 20512-20521Google 40Inoue Miyata Shimizu Isoxanthohumol stimulates ubiquitin-proteasome-dependent proteins.Biosci. Biotechnol. 82: 1591-1598Google Scholar) propagation (41Zhang Cheng Protease RNF20 facilitates via stabilization SREBP1.Proc. Natl. Acad. U. 118e2107108118Google Despite localization Nsp3, little investigation possible modulating ERAD. We therefore examined exogenously SREBP-1, reveal catalytically impacts ways decreasing and, unexpectedly, sites. contrast observe require most anchoring enzyme. Overall, our potentially underappreciated important determining fate partition Full-length coronaviruses prior formation complex, incorporates (2Kanjanahaluethai To confirm assessed FLAG-tagged (Nsp3FL) (Fig. 1A -schematic). Both truncations begin just before One terminates immediately (Nsp3PLpro), extends predicted adjacent amphipathic helix (Nsp3TM) Nsp3FL Nsp3TM colocalize calnexin ER, Nsp3PLpro does 1, B C). levels transfected multitransmembrane substrate. markedly delays loss cycloheximide (CHX) chase HEK293T cells 1D). results 1E). Similarly, unlike Nsp3TM, inactive Cys111 Ala (Nsp3TMC111A) increase 1F), WT mutant coimmunoprecipitate S1A). Similar activity–dependent observed HeLa S1B). Null Hong Kong (NHK) variant alpha1-antitrypsin, luminal employed model (36Smith 42Zhong Shen Fang Identification dislocation null α-1-antitrypsin (NHK).Biochem. 458: 424-428Google 43Christianson Shaler T.A. Tyler OS-9 GRP94 deliver alpha1-antitrypsin Hrd1-SEL1L ERAD.Nat. 2008; 272-282Google 44Klemm E.J. Spooner Ploegh H.L. Dual ancient ubiquitous (AUP1) droplet accumulation control.J. 2011; 286: 37602-37614Google 1G) Importantly, Nsp3TMC111A marked without altering total ubiquitination, proteasome prevent 1H). consistent functioning INSIG-1. next evaluated ER-localized Like closely spaced termini facing T7-tagged forms, 2A). then coexpression stability cells. Nsp3TMC111A, unexpected acceleration over h treatment CHX 2B, upper panel arrow). Overexpression variable amounts T7 immunoreactive species 70 kDa range bracket). (45Hua Regulated element binding sequences sides membrane.J. 1996; 271: 10379-10384Google may represent translocated cleaved and/or S2P. Most strikingly, however, result migrating ∼45 arrowhead). No evidence species, accelerated apparent 2C). Figure 2, epitope-tagged E-tag, lacking tag it similarly affected S2A). Except indicated, E-tagged used rest study. had effect NTD corresponds factor (Figs. 2D S2B). striking inhibit 2E). Nsp3TMC111A. Soluble SREBP-2, albeit lesser extent 2F). understand basis Nsp3-dependent appearance compared migration truncations. second Gly residues (diGly). Leu invariably position (LXGG) There number diGlys SREBP-1. Because weights, generated following aa 437-438 317-318, despite neither having P4. comparison, NTD, ends 520 3A schematic). phosphatase treatment, 318 truncation approximates products 3B, lanes 5–8). Notably, lacks basic helix-loop-helix leucine zipper motif, transcriptional 46Brown A proteolytic controls content membranes, cells, blood.Proc. 1999; 96: 11041-11048Google further evaluate cleavage, diGly 317 (A317-318) deleted amino acids (Δ317-318) – mutations). Neither eliminated 3C 4). entertained possibility more one closest 100 direction 200-201 aforementioned 437-438. AlaGly 23 340-341, includes deletion 338-348 (Δ338-348) combination A317-318 mutation resulted lower weight lane 5 Fig. 3D 3). Δ338-348 support proximity. supported comparing relative terminal–containing 4 5), each leave only intact. encompassing Gly341, hereafter designated point individual context mutation, designate 1. mutations retaining sequence top 5–10, 6-10 underlined—see schematic 3A). demonstrates (P1) cutting, P4, Arg P5 7, 6, 8, respectively). implicate adequate flexibility allow P2. determine P2 significance, Leu, larger hydrophobic acid, Glu, acidic residue. cutting 9–10). Thus, represents site. Further confirmation shown comigration intact corresponding S3A). S3B). 3D, immunoblot monoclonal antibody 2A4 (47Sato Evans M.J. Ho Y.K. al.Assignment attachment, DNA binding, protein-1 (SREBP-1).J. 1994; 269: 17267-17273Google reveals ∼90 detected blotting. bands complementary 2. E-tag (see S3C complete autoradiograph 3D). Strikingly, immunoreactivity almost completely lost co-expression regardless mutations. likely explanation lies RLGGG near terminus (1167–1171; see schematic, investigate immunoreactivity, systematic 1167-1171, referred now 3, undertaken. Mutation Gly1171 Leu1168 retenti

Язык: Английский

SARS‐CoV‐2 Papain‐Like Protease: Structure, Function and Inhibition DOI
Sven Ullrich, Christoph Nitsche

ChemBioChem, Год журнала: 2022, Номер 23(19)

Опубликована: Авг. 22, 2022

Abstract Emerging variants of SARS‐CoV‐2 and potential novel epidemic coronaviruses underline the importance investigating various viral proteins as drug targets. The papain‐like protease has been less explored than other proteins; however, its substantive role in replication impact on host immune response make it a suitable target to study. This review article focuses structure function (PL pro ) SARS‐CoV‐2, including concern, compares those coronaviruses, such SARS‐CoV‐1 MERS‐CoV. protease's recognition motif is mirrored ubiquitin ISG15, which are involved antiviral response. Inhibitors, GRL0617 derivatives, their prospects future agents also discussed.

Язык: Английский

Процитировано

43

Green and efficient one-pot three-component synthesis of novel drug-like furo[2,3-d]pyrimidines as potential active site inhibitors and putative allosteric hotspots modulators of both SARS-CoV-2 MPro and PLPro DOI Open Access
Hossein Mousavi, Behzad Zeynizadeh, Mehdi Rimaz

и другие.

Bioorganic Chemistry, Год журнала: 2023, Номер 135, С. 106390 - 106390

Опубликована: Янв. 28, 2023

Язык: Английский

Процитировано

26

Deubiquitinating activity of SARS-CoV-2 papain-like protease does not influence virus replication or innate immune responses in vivo DOI Creative Commons
Mariska van Huizen,

Jonna R. Bloeme - ter Horst,

Heidi L.M. De Gruyter

и другие.

PLoS Pathogens, Год журнала: 2024, Номер 20(3), С. e1012100 - e1012100

Опубликована: Март 25, 2024

The coronavirus papain-like protease (PLpro) is crucial for viral replicase polyprotein processing. Additionally, PLpro can subvert host defense mechanisms by its deubiquitinating (DUB) and deISGylating activities. To elucidate the role of these activities during SARS-CoV-2 infection, we introduced mutations that disrupt binding to ubiquitin or ISG15. We identified several strongly reduced DUB activity PLpro, without affecting In contrast, abrogated also hampered processing when into virus mutants were not viable. exhibiting elicited a stronger interferon response in human lung cells. mouse model severe disease, disruption did affect lethality, replication, innate immune responses lungs. This suggests dispensable replication does vivo . Interestingly, mutant SARS-CoV replicated slightly lower titers mice diminished early although lethality was unaffected. previously showed MERS-CoV deficient attenuated mice. Here, demonstrate infection vary considerably between highly pathogenic coronaviruses. Therefore, careful considerations should be taken developing pan-coronavirus antiviral strategies targeting PLpro.

Язык: Английский

Процитировано

12

Restriction of Viral Glycoprotein Maturation by Cellular Protease Inhibitors DOI Creative Commons
Rishikesh Lotke,

Moritz Petersen,

Daniel Sauter

и другие.

Viruses, Год журнала: 2024, Номер 16(3), С. 332 - 332

Опубликована: Фев. 22, 2024

The human genome is estimated to encode more than 500 proteases performing a wide range of important physiological functions. They digest proteins in our food, determine the activity hormones, induce cell death and regulate blood clotting, for example. During viral infection, however, some can switch sides activate glycoproteins, allowing entry virions into new target cells spread infection. To reduce unwanted effects, multiple protease inhibitors proteolytic processing self non-self proteins. This review summarizes current knowledge endogenous inhibitors, which are known limit replication by interfering with activation glycoproteins. We describe underlying molecular mechanisms highlight diverse strategies virion infectivity. also provide examples how viruses evade restriction imposed inhibitors. Finally, we briefly outline cellular be modified exploited therapeutic purposes. In summary, this aims summarize understanding as components immune response variety pathogens.

Язык: Английский

Процитировано

6

Repurposing 1,2,4-oxadiazoles as SARS-CoV-2 PLpro inhibitors and investigation of their possible viral entry blockade potential DOI Open Access
Mohammed Salah Ayoup,

Mariam M. ElShafey,

Hamida Abdel‐Hamid

и другие.

European Journal of Medicinal Chemistry, Год журнала: 2023, Номер 252, С. 115272 - 115272

Опубликована: Март 13, 2023

Язык: Английский

Процитировано

13

Structure-based design of SARS-CoV-2 papain-like protease inhibitors DOI Creative Commons
Prakash D. Jadhav, Bo Huang,

J. Osipiuk

и другие.

European Journal of Medicinal Chemistry, Год журнала: 2023, Номер 264, С. 116011 - 116011

Опубликована: Дек. 5, 2023

Язык: Английский

Процитировано

13

Bacterial ubiquitin ligases hijack the host deubiquitinase OTUB1 to inhibit MTORC1 signaling and promote autophagy DOI
Kelong Ma,

Wei Xian,

Hongtao Liu

и другие.

Autophagy, Год журнала: 2024, Номер 20(9), С. 1968 - 1983

Опубликована: Май 31, 2024

Many bacterial pathogens have evolved effective strategies to interfere with the ubiquitination network evade clearance by innate immune system. Here, we report that OTUB1, one of most abundant deubiquitinases (DUBs) in mammalian cells, is subjected both canonical and noncanonical during Legionella pneumophila infection. The effectors SidC SdcA catalyze OTUB1 at multiple lysine residues, resulting its association a Legionella-containing vacuole. Lysine promotes interactions between DEPTOR, an inhibitor MTORC1 pathway, thus suppressing signaling. inhibition leads suppression host protein synthesis promotion macroautophagy/autophagy L. In addition, members SidE family (SidEs) induce phosphoribosyl (PR)-linked Ser16 Ser18 block DUB activity. levels serine are further regulated function antagonize activities SidC, SidEs, including Lem27, DupA, DupB, SidJ SdjA. Our study reveals effectors-mediated complicated mechanism regulating activity DUB.

Язык: Английский

Процитировано

5

Preclinical and Clinical Investigations of Potential Drugs and Vaccines for COVID-19 Therapy: A Comprehensive Review With Recent Update DOI Creative Commons
Md. Easin Mia,

Mithu Howlader,

Farzana Akter

и другие.

Clinical Pathology, Год журнала: 2024, Номер 17

Опубликована: Янв. 1, 2024

The COVID-19 pandemic-led worldwide healthcare crisis necessitates prompt societal, ecological, and medical efforts to stop or reduce the rising number of fatalities. Numerous mRNA based vaccines for viral vectors have been licensed use in emergencies which showed 90% 95% efficacy preventing SARS-CoV-2 infection. However, safety issues, vaccine reluctance, skepticism remain major concerns making mass vaccination a successful approach treat COVID-19. Hence, alternative therapeutics is needed eradicating global burden from developed low-resource countries. Repurposing current medications drug candidates could be more viable option treating as these therapies previously passed significant checkpoints development patient care. Besides vaccines, this review focused on potential usage therapeutic agents including antiviral, antiparasitic, antibacterial drugs, protease inhibitors, neuraminidase monoclonal antibodies that are currently undergoing preclinical clinical investigations assess their effectiveness treatment Among repurposed remdesivir considered most promising agent, while favipiravir, molnupiravir, paxlovid, lopinavir/ritonavir exhibited improved effects terms elimination viruses. outcomes with oseltamivir, umifenovir, disulfiram, teicoplanin, ivermectin were not significant. It noteworthy combining multiple drugs therapy showcases impressive managing individuals Tocilizumab presently employed patients who exhibit COVID-19-related pneumonia. antiviral such galidesivir, griffithsin, thapsigargin under trials severe symptoms. Supportive may involve corticosteroids, convalescent plasma, stem cells, pooled antibodies, vitamins, natural substances. This study provides an updated progress crucial guide inventing novel interventions against

Язык: Английский

Процитировано

5

Repurposing clinically available drugs and therapies for pathogenic targets to combat SARS‐CoV‐2 DOI Creative Commons

Yiying Xue,

Husheng Mei,

Yisa Chen

и другие.

MedComm, Год журнала: 2023, Номер 4(3)

Опубликована: Май 14, 2023

The coronavirus disease 2019 (COVID-19) pandemic has affected a large portion of the global population, both physically and mentally. Current evidence suggests that rapidly evolving subvariants risk rendering vaccines antibodies ineffective due to their potential evade existing immunity, with enhanced transmission activity higher reinfection rates could lead new outbreaks across globe. goal viral management is disrupt life cycle as well relieve severe symptoms such lung damage, cytokine storm, organ failure. In fight against viruses, combination genome sequencing, elucidation structure proteins, identifying proteins are highly conserved multiple coronaviruses revealed many molecular targets. addition, time- cost-effective repurposing preexisting antiviral drugs or approved/clinical for these targets offers considerable clinical advantages COVID-19 patients. This review provides comprehensive overview various identified pathogenic pathways corresponding repurposed COVID-19. These findings provide insight into discovery novel therapeutic strategies be applied control emanating from SARS-CoV-2 variants.

Язык: Английский

Процитировано

11

Development of Fluorescence-Based Assays for Key Viral Proteins in the SARS-CoV-2 Infection Process and Lifecycle DOI Open Access

Mingzhenlong Deng,

Chuang Zhang, Wanli Yan

и другие.

International Journal of Molecular Sciences, Год журнала: 2024, Номер 25(5), С. 2850 - 2850

Опубликована: Март 1, 2024

Since the appearance of SARS-CoV-2 in 2019, ensuing COVID-19 (Corona Virus Disease 2019) pandemic has posed a significant threat to global public health system, human health, life, and economic well-being. Researchers worldwide have devoted considerable efforts curb its spread development. The latest studies identified five viral proteins, spike protein (Spike), main protease (3CLpro), papain-like (PLpro), RNA-dependent RNA polymerase (RdRp), helicase (Helicase), which play crucial roles invasion into body lifecycle. development novel anti-SARS-CoV-2 drugs targeting these proteins holds immense promise. Therefore, efficient, high-throughput screening methodologies specifically designed for is utmost importance. Currently, plethora techniques exists, with fluorescence-based assays emerging as predominant contenders. In this review, we elucidate foundational principles underpinning approaches directed at pivotal targets, hoping guide researchers judicious selection refinement strategies, thereby facilitating discovery lead compounds pharmaceuticals.

Язык: Английский

Процитировано

4